ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Myopathies"

  • Abstract Number: 2066 • ACR Convergence 2024

    Comparative Diagnostic Efficacy of Quantitative Measurement of Echo Intensity and Texture versus Qualitative Analysis of Ultrasound Images in Myositis

    Takeshi Yoshida1, Hiroki Yamazaki2, Naoko Takamatsu2, Yoshinori Taniguchi3, Taiki Nozaki4, masataka inoue5, Yoshitaka Kumon6, yuki matsumoto2, Yuki Kanazawa2, Masafumi Harada2, Ichizo Nishino7, Jemima Albayda8 and Yuishin Izumi2, 1Chikamori Hospital, Kochi, Kochi, Japan, 2Tokushima University School of Medicine, Tokushima, Japan, 3Kochi University School of Medicine, kochi, Japan, 4keio University School of Medicine, Tokyo, Japan, 5Hyogo Medical University, Nishinomiya, Japan, 6Chikamori Hospital, Kochi, Japan, 7National Center of Neurology and Psychiatry, Tokyo, Japan, 8Johns Hopkins School of Medicine, Baltimore, MD

    Background/Purpose: Recently, the role of imaging tests such as magnetic resonance imaging and ultrasound (US) in the diagnosis and classification of myositis has become increasingly…
  • Abstract Number: 1149 • ACR Convergence 2024

    Cause-Specific Proportionate Mortality Trends in Idiopathic Inflammatory Myopathies

    Ansaam Daoud1, Muhammad Shamim2, Loai Dweik3 and Haseeb Chaudhary4, 1Case Western Reserve University/University Hospitals, Akron, OH, 2University Hospitals/ Case Western Reserve University, Cuyahoga Falls, OH, 3Cleveland Clinic Akron General Internal Medicine, Akron, OH, 4Case Western Reserve University, Westlake, OH

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are associated with increased morbidity, mortality, and economic health burden compared to the general population despite advancements in overall disease management.…
  • Abstract Number: 2067 • ACR Convergence 2024

    Clinical and Laboratory Characterization of Overlap Connective Tissue Disease in Patients with Idiopathic Inflammatory Myopathies: Results from the MYOTReCSZ Cohort

    karina santana1, Jiram Torres Ruiz2, Diana Gómez-Martin3, María José Ostos-prado4, Yatzil Reyna-Juárez4, Beatriz Alcalá-Carmona4, Mariana Arroyo5 and Nancy R Mejía-Domínguez4, 1INCMNSZ, Ciudad de México, Distrito Federal, Mexico, 2INCMNSZ, Mexico, Federal District, Mexico, 3INCMNSZ, Mexico, Distrito Federal, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Distrito Federal, Mexico, 5Angeles Interlomas, Mexico, Distrito Federal, Mexico

    Background/Purpose: Idiopathic Inflammatory Myopathies (IIM) comprise systemic autoimmune dosorders which may occur in patients with other conective tissue diseases (CTD). The coexistence of IIM with…
  • Abstract Number: 1152 • ACR Convergence 2024

    Nailfold Videocapillaroscopy Abnormalities in Different Autoimmune Inflammatory Myopathy Subsets

    Thaisa Cotton1, Valérie Leclair2, Claudie Berger3, Yves Troyanov4, marie Hudson2 and Geneviève Gyger2, and Canadian Inflammatory Myopathy Study (CIMS), 1Université de Montréal, Montreal, QC, Canada, 2McGill University, Montreal, QC, Canada, 3Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 4Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada

    Background/Purpose: Nailfold videocapillaroscopy (NVC) alterations have mostly been described in autoimmune inflammatory myopathies (AIM) classified using Bohan and Peter criteria. The aim of this study…
  • Abstract Number: 2071 • ACR Convergence 2024

    Self-Efficacy Contributes to Better Health Outcomes in Patients of Idiopathic Inflammatory Myopathies: Insights from the COVAD 3 Dataset

    praggya yaadav1, Maria Rosa Pellico2, Anne-Marie Russell3, Aviya Lanis4, Elena Nikiphorou5, Ioannis Parodis6, Sreoshy Saha7, Manali Sarkar8, Jasmine Parihar9, Laura Andreoli10, Vikas Agarwal11 and Latika Gupta12, and COVAD Steering Committee, COVAD Study Group, 1Maharashtra Institute of Medical Sciences and Research, Latur, Aurangabad, India, 2University of Milan, Milan, Italy, 3Birmingham Regional Interstitial Lung Disease Service, University Hospitals Birmingham NHS Trust and Faculty of Life Sciences, University of Exeter, Exeter, UK, Birmingham, United Kingdom, 4Seattle Children's Hospital, Seattle, WA, 5King's College London, London, United Kingdom, 6Karolinska Institutet, Karolinska University Hospital; Örebro University, Solna, Sweden, 7Mymensingh Medical College, Mymensingh, Bangladesh, 8MGM Medical College, Navi Mumbai, Maharashtra, India, 9All India Institute of Medical Science, New Delhi, Delhi, India, 10University of Brescia, Brescia, Italy, 11Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 12Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom

    Background/Purpose: Self-efficacy is crucial for chronic disease management. Given the increasing prevalence of chronic diseases, encouraging patients to actively manage their disease may be an…
  • Abstract Number: 1155 • ACR Convergence 2024

    Stratification of Cancer Risk in Idiopathic Inflammatory Myopathies. Application of the IMACS Guidelines to Enhance Screening

    Miriam Retuerto Guerrero1, Clara Moriano2, cristiana sieiro santos3 and elvira Diez álvarez4, 1Complejo Asistencial Universitario de León, Leon, Spain, 2Hospital León, LEON, Spain, 3Rheumatology Department, Complejo Asistencial Universitario de León, León, Spain, Leon, Spain, 4Complejo Asistencial Universitario de Leon, Leon

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) carry an elevated risk of cancer incidence. Recently published International Guidelines for IIM-associated cancer screening from the Myositis Assessment and…
  • Abstract Number: 2073 • ACR Convergence 2024

    Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison

    Carina Soto-Fajardo1, Alejandra Espinosa-Orantes2, Alejandra Enríquez-Luna3, Fabian Carranza Enriquez4, Tabata Cano-Gamez3, Ana Mora-Rosas5, Rosa Elena Cervantes-Ramirez5, Karen Contreras-Castillo5, Jiram Torres Ruiz6, Diana Gómez-Martin7 and Carlos Pineda8, 1Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 2Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 3Instituto Nacional de Rehabilitacion, Mexico, Distrito Federal, Mexico, 4Instituto Nacional de Rehabilitación \"Luis Guillermo Ibarra Ibarra\", Ciudad de México, Mexico, 5Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico, Distrito Federal, Mexico, 6INCMNSZ, Mexico, Federal District, Mexico, 7INCMNSZ, Mexico, Distrito Federal, Mexico, 8Instituto Nacional de Rehabilitacion, Mexico City, Distrito Federal, Mexico

    Background/Purpose: Muscle ultrasound (MUS) is a non-invasive tool that may explore the extent of muscle abnormalities and contribute to early diagnosis and follow-up of patients…
  • Abstract Number: 1159 • ACR Convergence 2024

    Anti-synthetase Syndrome (ASSD) Related Interstitial Lung Disease (ILD) in Comparison to Non-ASSD Related ILDs: Analysis from the “Classification Criteria for Anti-synthetase Syndrome (CLASS)” Project Database

    Sangmee Bae1, Francisca Bozan2, Daphne Rivero Gallegos3, Giovanni Zanframundo4, Sara Faghihi-Kashani5, iazsmin Ventura6, Eduardo Dourado7, Aravinthan Loganathan8, Gianluca sambataro9, Akira Yoshida10, Francesco Bonella11, Tamera J Corte12, Tracy J Doyle13, david fiorentino14, Miguel Angel Gonzalez-Gay15, marie Hudson16, Masataka Kuwana17, Antonella Notarnicola18, Andrew Mammen19, Neil McHugh20, Frederick Miller21, Carlomaurizio Montecucco22, Chester Oddis23, Jorge Rojas-Serrano24, Jens Schmidt25, Carlo Scire26, Albert Selva-O’Callaghan27, Victoria Werth28, Lorenzo Cavagna29 and Rohit Aggarwal30, 1UCLA, Los Angeles, CA, 2Hospital Clinico Universidad de Chile, Santiago, Chile, 3INER, Ciudad de México, Mexico State, Mexico, 4Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, Milano, Italy, 5Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, San Francisco, CA, 6Section of Rheumatology, University of Chicago, Chicago, IL, 7Unidade Local de Saúde da Região de Aveiro, Aveiro, Portugal, 8RUH, Middle Park, Queensland, Australia, 9University of Catania, Catania, Italy, 10Nippon Medical School Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan, 11Center for interstitial and rare lung diseases, Ruhrlandklinik, University of Duisburg-Essen, Essen, Germany, 12Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia, 13Brigham and Women's Hospital, West Roxbury, MA, 14Department of Dermatology, Stanford University School of Medicine, Stanford, CA, Palo Alto, CA, 15University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 16McGill University, Montreal, QC, Canada, 17Department of Allergy and Rheumatology, Nippon Medical School, Tokyo, Japan, Tokyo, Japan, 18Karolinska University Hospital and Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 19NIH, Bethesda, MD, 20University of Bath, Bath, United Kingdom, 21NIH, NIEHS, Chapel Hill, NC, 22IRCCS policlinico S. Matteo foundation, University of Pavia, Pavia, Italy, 23Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 24National Institute of Respiratory Diseases, Ismael Cosío Villegas, Mexico City, Mexico, 25University Medical Center Goettingen, Göttingen, Germany, 26University of Milano Bicocca, Milan, Italy, 27Internal Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain, 28University of Pennsylvania, Wynnewood, PA, 29University of Pavia, Pavia, Italy, 30Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: Anti-synthetase syndrome (ASSD) is a subset of idiopathic inflammatory myopathy characterized by autoantibodies directed against aminoacyl tRNA synthetases. Interstitial lung disease (ILD) can be…
  • Abstract Number: 2074 • ACR Convergence 2024

    Experience on the Use of Obinutuzumab off Label in Patients with Refractory Idiopathic Inflammatory Myopathy

    Ivana Ilic1 and Galina Marder2, 1Northwell, Brooklyn, NY, 2Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Great Neck, NY

    Background/Purpose: Idiopathic inflammatory myopathy (IIM) is a rare multisystem inflammatory condition leading to significant disability. The management of IIM remains challenging. B cell targeting therapies are…
  • Abstract Number: 0301 • ACR Convergence 2023

    Inflammatory Myopathies and Their Relationship with Cancer in a Colombian Cohort

    Bolaños Juan D.1, Rivera-Londoño Robert1, Ivana Nieto-Aristizabal1, Karol Enriquez2, Santiago Zura2, Alex Echeverri1, Andrés Hormaza-Jaramillo1 and David Aguirre-Valencia1, 1Fundación Valle del Lili, Cali, Colombia, 2Universidad ICESI, Cali, Colombia

    Background/Purpose: Inflammatory myopathies (IM) constitute a heterogeneous group of autoimmune muscle diseases. These can occur in isolation, associated with other autoimmune disorders, or as a…
  • Abstract Number: 1949 • ACR Convergence 2023

    Relapse of Rapidly Progressive Interstitial Lung Disease in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Autoantibody-Positive Dermatomyositis

    Noriko Sasaki, Toshiki Ohisa, Akira Ishii, Mai Sugiyama, Yuichiro Ota, Chiho Yamada and Shinji Sato, Tokai university School of Medicine, Isehara, Japan

    Background/Purpose: Autoantibodies to Melanoma Differentiation-Associated Gene 5 (MDA5) are found specifically in patients with dermatomyositis (DM). Their presence is closely associated with rapidly progressive interstitial…
  • Abstract Number: 0651 • ACR Convergence 2023

    Abnormal Nailfold Video-capillaroscopy Is Independently Associated with non-UIP Radiographic Patterns in Autoimmune ILD: A Multicenter Study from the NEREA Registry

    Jesus Loarce-Martos1, Hilda Godoy2, Laura Cebrian3, M Jesus Rodriguez-Nieto4, Juan Rigual5, Rosalía Laporta2, Belen Lopez-Muñiz3, lydia Abasolo6, Olga Sanchez Pernaute7 and Fredeswinda Romero7, 1Ramón y Cajal University Hospital, Madrid, Spain, 2Hospital Universitario Puerta de Hierro, Madrid, Spain, 3Hospital Universitario Infanta Leonor, Madrid, Spain, 4Pulmonology department, Hospital Fundación Jimenez Díaz, Madrid, Spain, 5Pulmonology department, Hospital Ramón y Cajal,, Madrid, Spain, 6Hospital Clínico San Carlos, Madrid, Spain, 7IIS-HU Fundación Jiménez Díaz, Madrid, Spain

    Background/Purpose: The aim of this study is to describe the nailfold video-capillaroscopy (NVC) findings in patients with interstitial lung disease associated to connective tissue diseases…
  • Abstract Number: 1950 • ACR Convergence 2023

    Thromboembolic Risk Associated with Intravenous Immune Globulin Use in Patients with Idiopathic Inflammatory Myopathy: A Large Database Study

    Rohan Mehta1, Mike Putman2 and Didem Saygin3, 1Medical College of Wisconsin, Milwaukee, WI, 2Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI, 3University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Intravenous immune globulin (IVIG) recently received regulatory approval for the treatment of dermatomyositis, one of the idiopathic inflammatory myopathies (IIM). The pivotal randomized trial…
  • Abstract Number: 0664 • ACR Convergence 2023

    Quantitative Hand Held Dynamometry to Assess Muscle Strength in Scleroderma Associated Myopathy

    Julie Paik1, Christopher Mecoli2, Anshula Nallapati1, Ami Shah3, Fred Wigley4, Zsuzsanna McMahan5 and Laura Hummers1, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Ellicott City, MD, 4Department of Rheumatology, Johns Hopkins Medicine, Baltimore, MD, 5Johns Hopkins Rheumatology, Lutherville, MD

    Background/Purpose: Manual muscle strength testing can be challenging in SSc associated myopathy (SSc-AM) due to contractures or skin tightening. Since there is currently no validated…
  • Abstract Number: 1953 • ACR Convergence 2023

    Mortality Trends in Polymyositis and Dermatomyositis in Mexico: A General Population-based Study from 2000 to 2019

    CLAUDIA MENDOZA PINTO1, Pamela Munguía-Realpozo1, Ivet Etchegaray-Morales2, Mario García-Carrasco2, Paulina Cortés-Hernández1, Roberto Arreguín-Reyes1, Jorge Ayón-Aguilar1 and Gabriel Rodríguez-Castillo2, 1Instituto Mexicano del Seguro Socia, Puebla, Mexico, 2Medicine School, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico

    Background/Purpose: Patients with polymyositis and dermatomyositis (PM/DM) present multiple complications that may lead to increased mortality rates and data on PM/DM mortality in Mexico is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology